10 Analyst Stock Picks Under $10 for Massive Upside

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
10 Analyst Stock Picks Under $10 for Massive Upside

© Thinkstock

[cnxvideo id=”655422″ placement=”ros”]24/7 Wall St. is constantly on the hunt for undiscovered opportunities and hidden value in the financial markets. Even in hard times there are always some opportunities that can be found. Each morning of the week we review dozens of analyst upgrades, downgrades and initiations, which ends up being hundreds of analyst calls each week. These calls are made from bulge bracket firms like Goldman Sachs and Merrill Lynch all the way down to regional and boutique firms whose investor reach and influence is generally smaller.

One category of analyst calls that often comes with great upside is in the small-cap and low-priced stocks. Some of these stocks trade under $10 per share. Frequently in this category of cheap and small cap stocks the projected analyst upside just seems ludicrous. Other times it seems more reasonable, and in many cases the stocks have traded at those levels before.

24/7 Wall St. tries to warn its readers endlessly that it is best not to trust any analyst call blindly. The reality is that there is no free lunch on Wall Street. Where else can you get your call right, but the timing can be days or hours off?

Array BioPharma Inc. (NASDAQ: ARRY) was initiated with an Outperform rating and a $9 price target at Cowen on September 12. Shares closed Friday at $3.47, with a consensus analyst price target of $8.00 and a 52-week trading range of $2.38 to $5.87.

Boingo Wireless Inc. (NASDAQ: WIFI) was started as Outperform with a $12 price target on September 13. Shares of Boingo were last trading at $9.13. The consensus price target is $11.01, and the 52-week range is $5.40 to $9.88.

[nativounit]

Eldorado Gold Corp. (NYSE: EGO) was raised to Buy from Underperform with a $5 price objective Merrill Lynch on September 14. Shares were closed most recently at $3.99, in a 52-week range of $1.87 to $5.16. The consensus price target is $5.76.

Energy Recovery Inc. (NASDAQ: ERII) was upgraded to a Buy rating from Hold at Jefferies on September 13, with a price target of $20. Jefferies noted a triple thesis: high incremental margins, recovery in the core desalination market and validation of the broader theme of harvesting fluid pressure in high-pressure and toxic environments. Shares closed out the week at $14.57, with a consensus price target of $15.75 and a 52-week range of $2.07 to $14.65.

Extreme Networks Inc. (NASDAQ: EXTR) was raised to a Buy rating from Neutral at D.A. Davidson. The stock was most recently trading at $4.23 a share. The consensus analyst target is $5.26. The 52-week range is $2.32 to $4.55.

Mirna Inc. (NASDAQ: MIRN) was started with a Buy rating and assigned a $6 price target at H.C. Wainwright on September 12. Shares closed at $2.25, with a consensus price target of $7.38 and a 52-week range of $2.23 to $11.01.

Xerox Corp. (NYSE: XRX) was started with a Buy rating and assigned a $13 price target at SunTrust Robinson Humphrey. Remember that Xerox is breaking itself up. The stock has a 52-week range of $8.48 to $11.39 and a consensus price target of $11.32. Shares closed Friday at $9.80.

Xplore Technologies Corp. (NASDAQ: XPLR) was initiated as a Buy rating with a $5 price target at Maxim Group. Shares were last trading at $2.25. The consensus price target is $3.70, and the 52-week range is $2.10 to $6.15.

[wallst_email_signup]

Demand Media Inc. (NYSE: DMD) was initiated with a Buy rating and a $10 price target at Craig Hallum on September 12. Shares closed at $5.91 apiece, with a consensus price target of $7.07 and a 52-week range of $3.94 to $6.47.

Oasmia Pharmaceutical AB (NASDAQ: OASM) was initiated as a Buy with a $6 price target at Rodman & Renshaw. Shares closed Friday at $3.39, in a 52-week range of $2.75 to $5.25. The consensus analyst target is $6.00.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618